EUVIMEDEUVIMED entdecken
Crossref

Eupatilin inhibits xanthine oxidase in vitro and attenuates hyperuricemia and renal injury in vivo

Guitao Xu, Lele Wu, Hongxuan Yang, Tianfeng Liu, Ying Tong, Jiliang Wan, Bin Han, Lin Zhou, Xuguang Hu

Food and Chemical Toxicology · 2024

DOI: 10.1016/j.fct.2023.114307 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Food and Chemical Toxicology, 2024. Verfasst von Guitao Xu und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Chinese Materia Medica, Guangdong Pharmaceutical University, Guangzhou, 510006, PR China. Hauptthemen laut MEDLINE: Hyperuricemia. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Uric acid (UA) is the final metabolite of purines in the liver that can cause hyperuricemia at high levels. The kidneys are the main excretory organs for UA. The excessive accumulation of UA in the kidneys causes the development of hyperuricemia that often leads to renal injury. Eupatilin (Eup) is a flavonoid natural product that possesses various pharmacological properties such as antioxidant, anti-cancer, and anti-inflammatory. We were interested in exploring the potential role of Eup in lowering UA and nephroprotective. We initially investigated the effects of Eup on xanthin oxidase (XOD) activity in vitro, followed by investigating its ability to lower UA levels, anti-inflammatory effects, nephroprotective effects, and the underlying mechanisms using hyperuricemia rats sustained at high UA level. The results showed that Eup had an inhibitory effect on XOD activity in vitro and significantly reduced serum UA, creatinine, BUN, IL-1β and IL-6 levels in hyperuricemic rats, ameliorating inflammation, renal oxidative stress and pathological injury. Furthermore, Eup inhibited ADA and XOD enzyme activities in the liver and serum and modulated GLUT9, URAT1 and ABCG2 protein expression in the kidneys and ileum. Our findings provide a scientific basis for suggesting Eup as an option for a potential treatment for hyperuricemia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperuricemiaRatsAnimalsXanthine OxidaseKidneyFlavonoidsUric AcidAnti-Inflammatory Agents

Stichwörter der Autor:innen

EupatilinHyperuricaemiaRenal injuryUrate transporterUric acidXanthine oxidase

Substanzen

Xanthine OxidaseeupatilinFlavonoidsUric AcidAnti-Inflammatory Agents

Autor:innen und Institutionen

  • School of Chinese Materia Medica, Guangdong Pharmaceutical University, Guangzhou, 510006, PR China.
  • Guangdong Provincial Key Laboratory of Advanced Drug Delivery, Guangdong Provincial Engineering Center of Topical Precise Drug Delivery System, School of Life Sciences and Biopharmaceutics, Guangdong Pharmaceutical Univ…
  • School of Chinese Materia Medica, Guangdong Pharmaceutical University, Guangzhou, 510006, PR China. Electronic address: hxguang2@foxmail.com.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Xu, G., Wu, L., Yang, H., Liu, T., Tong, Y., Wan, J., Han, B., Zhou, L., & Hu, X. (2024). Eupatilin inhibits xanthine oxidase in vitro and attenuates hyperuricemia and renal injury in vivo. Food and Chemical Toxicology. https://doi.org/10.1016/j.fct.2023.114307

Vancouver

Xu G, Wu L, Yang H, Liu T, Tong Y, Wan J, et al. Eupatilin inhibits xanthine oxidase in vitro and attenuates hyperuricemia and renal injury in vivo. Food and Chemical Toxicology. 2024. doi:10.1016/j.fct.2023.114307

BibTeX
@article{Xu2024,
  author = {Xu, Guitao and Wu, Lele and Yang, Hongxuan and Liu, Tianfeng and Tong, Ying and Wan, Jiliang and Han, Bin and Zhou, Lin and Hu, Xuguang},
  title = {Eupatilin inhibits xanthine oxidase in vitro and attenuates hyperuricemia and renal injury in vivo},
  journal = {Food and Chemical Toxicology},
  year = {2024},
  doi = {10.1016/j.fct.2023.114307}
}
Kostenlos starten →